Zacks Research Has Negative Forecast for Amgen Q2 Earnings
Amgen Inc. (NASDAQ:AMGN – Free Report) – Equities research analysts at Zacks Research lowered their Q2 2025 EPS estimates for Amgen in a report released on Thursday, May 22nd. Zacks Research analyst R. Department now anticipates that the medical research company will earn $5.20 per share for the quarter, down from their previous forecast of […]
Amgen Inc. (NASDAQ:AMGN – Free Report) – Equities research analysts at Zacks Research lowered their Q2 2025 EPS estimates for Amgen in a report released on Thursday, May 22nd. Zacks Research analyst R. Department now anticipates that the medical research company will earn $5.20 per share for the quarter, down from their previous forecast of […]
